Taxanes for breast cancer: an evidence-based review of randomized phase II and phase III trials

Clinical Breast Cancer
J A Sparano

Abstract

The taxanes paclitaxel and docetaxel have an important role in the treatment of breast cancer, and numerous randomized trials have evaluated their efficacy for this indication. A systematic, evidence-based review was performed, which included all randomized, controlled trials evaluating taxanes for the treatment of early-or advanced-stage breast cancer that were identified in CANCERLIT and MEDLINE searches. The primary objectives of this review were to determine the dose and schedule for each taxane that was associated with the most favorable therapeutic index, and to determine whether (and under what circumstances) the taxanes improved survival. The search revealed 18 randomized phase II (n = 1) or phase III (n = 17) trials. For metastatic breast cancer, the dose and schedule associated with the most favorable therapeutic index for paclitaxel was 175 mg/m2 given as a 3-hour infusion every 3 weeks, and docetaxel was 60-100 mg/m2 given as a 1-hour infusion every 3 weeks. Survival was improved under the following circumstances: (1) when 4 cycles of paclitaxel (175 mg/m2 every 3 weeks) was given following 4 cycles of conventional doxorubicin-cyclophosphamide for axillary node-positive operable breast cancer, (2) when trastuzumab w...Continue Reading

References

Jan 1, 1994·Cell Biology International·H VerschuerenP De Baetselier
Jan 1, 1993·Kidney International·M L StrackeE Schiffmann
Mar 1, 1997·Annals of Internal Medicine·D J CookR B Haynes
Mar 10, 1998·Anti-cancer Drugs·A SparreboomJ H Beijnen
Nov 25, 2000·Breast Cancer : the Journal of the Japanese Breast Cancer Society·M AbeS Miura
Nov 25, 2000·Breast Cancer : the Journal of the Japanese Breast Cancer Society·Y AdachiS Kitano

❮ Previous
Next ❯

Citations

Apr 19, 2008·The New England Journal of Medicine·Joseph A SparanoNancy E Davidson
Dec 20, 2012·PloS One·Katrin OrlowskiMartin Pruschy
Apr 13, 2012·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Martha R C BhattacharyaAaron DiAntonio
Sep 27, 2003·Expert Review of Molecular Diagnostics·Jeffrey S RossLajos Pusztai
Sep 23, 2008·Expert Opinion on Pharmacotherapy·Emmanouel SaloustrosVassilis Georgoulias
Dec 19, 2003·Expert Opinion on Pharmacotherapy·Filippo MontemurroMassimo Aglietta
Feb 14, 2013·Current Medical Research and Opinion·Baris BoyrazKadri Altundag
Oct 21, 2004·Cancer Investigation·Matthew H KulkeCharles S Fuchs
Jul 7, 2011·Clinical Breast Cancer·Howard A BurrisGail D Lewis Phillips
Sep 11, 2007·American Journal of Otolaryngology·George H YooHo-Sheng Lin
Dec 20, 2007·Clinical Pharmacology and Therapeutics·S Moulder, G N Hortobagyi
Jun 12, 2012·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Carla Rohrer BleyMartin Pruschy
Jan 22, 2011·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Carolien P SchröderPax H Willemse
Feb 20, 2015·Journal of the National Cancer Institute·Angela Broggini-TenzerMartin Pruschy
Jan 31, 2013·Clinical Journal of Oncology Nursing·Sandra Binder
Aug 20, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Clifford Hudis
Jun 3, 2017·International Journal of Molecular Sciences·Alma D Campos-ParraCarlos Pérez-Plasencia
Feb 6, 2004·Molecular & Cellular Proteomics : MCP·Jeffrey S RossGabriel N Hortobagyi
Mar 29, 2018·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Tae Hoon KongYoung Joon Seo
Mar 9, 2005·Breast Cancer Research and Treatment·Kan YonemoriYasuhiro Fujiwara
Aug 5, 2003·The Oncologist·Jeffrey S RossKenneth J Bloom
Nov 7, 2017·Cancers·Laura L ThompsonKirk J McManus
Jun 16, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J A SparanoA C Wolff
Feb 24, 2017·Infectious Agents and Cancer·V VanderpuyeD C Stefan
May 27, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·William E CarsonBarbara L Andersen
Sep 25, 2019·Seminars in Cancer Biology·Sadhna AggarwalSubash Chandra Gupta
Nov 9, 2006·Archives of Pathology & Laboratory Medicine·Patrick L FitzgibbonsUNKNOWN Immunohistochemistry Committee, College of American Pathologists
Oct 1, 2021·Frontiers in Oncology·Jin-Hai TianLi-Bin Wang

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.